Pavmed last week dramatically trimmed its pending initial public offering, saying it plans to float 1.2 million shares at $5 apiece for gross proceeds of $6 million. That’s a far cry from the $23 million top end Pavmed listed when it registered the IPO last May. Pavmed is developing devices in 5 areas, according to its […]
Vortex Medical
BSX aims for double-digit earnings growth | Medtech Wall Street news for the week of May 4, 2015
Pavmed files for $23m IPO
The entrepreneurs behind a quartet of medical device companies is betting their formula can cut down on the time and cost of getting medtech to market with a $23 million initial public offering.
St. Jude Medical-backed Nanostim drums up $10M | Wall Street Beat
Nanostim, the Sunnyvale, Calif.-based company that’s developing a leadless pacemaker, raised $10 million in an equity and options deal, according to a regulatory filing.
AngioDynamics slides hard on Street-beating quarter, earnings-lowering acquisition
AngioDynamics (NSDQ:ANGO) shares took a dive as the company released its 1st quarter earnings report, announced an acquisition worth at least $55 million over the next 5 years and disclosed a shareholder class action lawsuit filed late last month.
